Related Experiment Video
Updated: Sep 15, 2025

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Publication of data sharing statements in clinical trials by cardiovascular journals: a quantitative and qualitative
Yingxin Liu1, Gregory Y H Lip2,3, Jingyi Zhang1
1Center for Clinical Epidemiology and Methodology (CCEM), The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou, China.
Abstract:
Many cardiovascular disease (CVD) journals request data sharing statements upon trial report submission, but their compliance in publishing these statements remains unclear. We therefore performed a quantitative analysis to evaluate the current practice of the publications of data sharing statements in clinical trials by CVD journals, which included 78 CVD journals that published clinical trials from Jan 2019 to Dec 2022 and had data sharing statement request. Multivariable logistic regression analysis was used to examine the association between journal characteristics and journals' publications of statements. We also ran an online qualitative survey by sending anonymous questionnaires to editors-in-chief from CVD journals for their opinions on journals' publications of statements, trying to further explore why the journals did not publish statements. Their perspectives could provide in-depth information on and new insights into promoting publications of data sharing statements. This quantitative and qualitative analysis assessing the current practice of publishing data sharing statements by CVD journals, may generate new evidence to promote the actual data sharing and transparency in CVD trials.
Related Concept Videos
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Coronary Artery Disease III: Clinical Manifestations
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

